MedTech AI leader recognized for 1,061% three-year revenue growth – topping the software category at no. 28 – and now valued at $955 million

BOSTON--(BUSINESS WIRE)--

AcuityMD, the AI platform for MedTech, today announced it has been named to the 2026 Inc. 5000 list of the fastest-growing private companies in America. AcuityMD ranked No. 316, driven by 1,061% three-year revenue growth – roughly 10 times the median revenue growth rate of 130% among 2026 Inc. 5000 honorees. The company also ranked No. 28 out of 362 software companies on the list. This marks AcuityMD’s first appearance on Inc. Magazine’s prestigious annual ranking.

The Inc. 5000 ranks the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, and Oracle. AcuityMD is one of a few software companies on the list focused on the MedTech industry.

“We’re proud to be recognized by Inc., but what matters most is what’s behind the growth: customers choosing AcuityMD to help them make better commercial decisions,” said Mike Monovoukas, CEO & Co-Founder of AcuityMD. “This milestone is a reflection of our team and our customers, and we’re excited to keep raising the bar for how AI can help accelerate the adoption of medical technology.”

Today, 16 out of the top 20 medical devices (MedTech) companies rely on AcuityMD to identify target markets, prioritize high-value physicians, and accelerate revenue growth. Their adoption underscores the growing role of AI in helping MedTech commercial teams navigate an increasingly complex market and make faster, more informed decisions.

In April, AcuityMD announced $80 million in new funding to elevate its platform with advanced AI capabilities. With the launch of AcuityAI, MedTech commercial teams now have purpose-built AI at their fingertips designed for their unique industry challenges. The platform combines rich domain expertise, data that maps relationships between sites of care and healthcare providers, and unique selling context to support specific MedTech commercial workflows. AcuityMD currently supports more than 500 customers and has helped these customers identify over $34 billion in pipeline. The company has raised upwards of $160 million and is valued at $955 million.

“Every company on the Inc. 5000 has a story of perseverance, smart decision-making, and a refusal to sit still,” says Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.”

For the full Inc. 5000 list, honoree company profiles, and a searchable database, visit: www.inc.com/inc5000. View AcuityMD’s profile from the list.

Inc. 5000 List Methodology

Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About AcuityMD

AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies – including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes’ 2025 “Next Billion-Dollar Startups” list – an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260812796731/en/

Source: AcuityMD